PADCEV EJFV

enfortumab vedotin · SEAGEN INC.

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for PADCEV EJFV, covering 2019-12-18 to 2025-11-21. Get the full timeline:

Most recent: FDA Approved: PADCEV EJFV — Supplemental Application (SEAGEN INC.)